🇺🇸 FDA
Patent

US 8158364

Methods and compositions involving nucleotide repeat disorders

granted A61PA61P21/00A61P25/28

Quick answer

US patent 8158364 (Methods and compositions involving nucleotide repeat disorders) held by The Board of Regents of the University of Texas System expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P21/00, A61P25/28, A61P31/00, A61P35/00